openPR Logo
Press release

Trastuzumab Biosimilars Market 2021 - Industry Size, Share, Growth, Trends and Global Forecast to 2030

04-07-2021 07:26 AM CET | Health & Medicine

Press release from: The Business research company

Trastuzumab Biosimilars Market

Trastuzumab Biosimilars Market

New year, new updates! Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports

The global trastuzumab biosimilars market is expected to grow from $1.22 billion in 2020 to $1.4 billion in 2021 at a compound annual growth rate (CAGR) of 14.8%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The trastuzumab biosimilar market is expected to reach $4.25 billion in 2025 at a CAGR of 32%.

The Business Research Company offers " Trastuzumab Biosimilars Global Market Report 2021: COVID-19 Growth And Change To 2030 " in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth, and highlights important trend s and strategies that players in the market can adopt.

Place a DIRECT PURCHASE ORDER of the report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3400

The trastuzumab biosimilar market consists of the sales of trastuzumab biosimilar and related services by entities (organizations, sole traders, and partnerships) that manufacture trastuzumab biosimilar. Trastuzumab is a monoclonal antibody that interferes with human epidermal growth factor receptor (HER2). Trastuzumab biosimilars are used mainly for the treatment of breast cancer and gastroesophageal junction adenocarcinoma or metastatic gastric.

Top Key Players in Trastuzumab Biosimilars Market:
• Amgen Inc.
• Pfizer Inc
• Samsung Bioepis
• Merck & Co.
• Biocon Limited
• Mylan Inc.
• BioXpress Therapeutics
• Celltrion
• Teva Pharmaceutical Industries Ltd.
• EirGenix, Inc

The countries covered in the global Trastuzumab Biosimilars Market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.

The regions covered in the global Trastuzumab Biosimilars Market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The global Trastuzumab Biosimilars Market is segmented -
1) By Product: Ogivri, Herzuma, Ontruzant, Trazimera, Others
2) By Indication: Adjuvant Breast Cancer, Metastatic Breast Cancer, Metastatic Gastric Cancer, Others
3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy

Browse Complete Report @ https://www.thebusinessresearchcompany.com/report/trastuzumab-biosimilars-market-global-report-2020-30-covid-19-growth-and-change

Few Points From Table Of Content
1. Executive Summary
2. Trastuzumab Biosimilars Market Characteristics
3. Trastuzumab Biosimilars Market Trends And Strategies
4. Impact Of COVID-19 On Trastuzumab Biosimilars Market
5. Trastuzumab Biosimilars Market Size And Growth
.....
26. Africa Trastuzumab Biosimilars Market
27. Trastuzumab Biosimilars Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Trastuzumab Biosimilars Market
29. Trastuzumab Biosimilars Market Future Outlook and Potential Analysis
30. Appendix

The report covers the trends and market dynamics of the Trastuzumab Biosimilars Market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Request for a Sample Copy of This Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=3400&type=smp

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Blog: http://blog.tbrc.info/

About Us:
The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology. TBRC excels in company, market, and consumer research.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Trastuzumab Biosimilars Market 2021 - Industry Size, Share, Growth, Trends and Global Forecast to 2030 here

News-ID: 2266844 • Views:

More Releases from The Business research company

Key Industry Players Strengthening Their Position In The Direct Coombs Test (DCT) Antibody Market
Key Industry Players Strengthening Their Position In The Direct Coombs Test (DCT …
The Direct Coombs Test (DCT) antibody market is gaining significant traction as advancements in medical diagnostics and growing healthcare needs drive demand. With innovations enhancing testing accuracy and expanding applications across diverse medical fields, this market is set to experience substantial growth in the upcoming years. Let's explore the market's projected size, key players, trends shaping the industry, and how the market is segmented. Direct Coombs Test (DCT) Antibody Market Size
Global Trends Analysis: How The Dental Practice Analytics Dashboards Market Is Rapidly Evolving
Global Trends Analysis: How The Dental Practice Analytics Dashboards Market Is R …
The dental practice analytics dashboards market is on track for significant expansion in the coming years, driven by the increasing use of data and technology in dental care management. As dental practices seek more efficient and patient-centered solutions, this market is set to grow rapidly, with new innovations and partnerships further enhancing its potential. Projected Market Size and Growth for Dental Practice Analytics Dashboards The market for dental practice analytics dashboards is
Datacenters Market Structure, Emerging Trends, And Leading Player Insights
Datacenters Market Structure, Emerging Trends, And Leading Player Insights
The datacenters market is on the verge of remarkable growth as digital transformation accelerates across multiple industries. Driven by cutting-edge technologies and changing business needs, this sector is set to expand rapidly in the coming years. Let's explore the current market size, the main companies involved, emerging trends, and the key segments shaping the future of datacenters globally. Steady Growth Forecast for the Datacenters Market by 2029 The global datacenters market is
Key Industry Players Strengthening Their Position In The Contract Food Service Management Market
Key Industry Players Strengthening Their Position In The Contract Food Service M …
The contract food service management sector is on track for notable expansion as consumer preferences and operational models evolve. Driven by rising health consciousness and technological advancements, this market is adapting to meet new demands while exploring innovative solutions. Let's delve into the current market size, key players, emerging trends, and major segments shaping the industry's future. Projected Market Value and Growth Dynamics in the Contract Food Service Management Market The contract

All 5 Releases


More Releases for Trastuzumab

Rising Breast And Gastric Cancer Prevalence Drives Trastuzumab Biosimilars Marke …
"The Trastuzumab Biosimilars Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Trastuzumab Biosimilars Market Size and Projected Growth Rate? The trastuzumab biosimilars market has seen rapid growth in recent years. It will grow from $4.27 billion in 2024 to $5.43 billion in 2025,
Leading Growth Driver in the Trastuzumab Biosimilars Market in 2025: Rising Brea …
What Are the Market Size and Growth Forecast for the Trastuzumab Biosimilars Market? The market for trastuzumab biosimilars has witnessed significant expansion in the past few years. The market is projected to increase from $4.27 billion in 2024 to $5.43 billion in 2025, with a compound annual growth rate (CAGR) of 27.1%. The historical growth patterns can be attributed to the expansion and globalization of the market, expiry of patents and
Leading Growth Driver in the Trastuzumab Biosimilars Market in 2025: Rising Brea …
What Are the Market Size and Growth Forecast for the Trastuzumab Biosimilars Market? The market for trastuzumab biosimilars has witnessed significant expansion in the past few years. The market is projected to increase from $4.27 billion in 2024 to $5.43 billion in 2025, with a compound annual growth rate (CAGR) of 27.1%. The historical growth patterns can be attributed to the expansion and globalization of the market, expiry of patents and
Herceptin (Trastuzumab) Market Overview,Recent Devolopment And Forecast During ( …
This report presents an overview of global market for Herceptin (Trastuzumab), capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028. This report researches the key producers of Herceptin (Trastuzumab), also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Herceptin (Trastuzumab), and key regions/countries of
Trastuzumab Biosimilar Market Opportunities and Growth Challenges Report 2022-20 …
Global Trastuzumab Biosimilar Market 2022-2028 - Global Industry Size, Supply Analysis, Price Analysis, Consumption and Production, Supplier and Cost Structure Analysis Trastuzumab Biosimilar Market Overview The recent market intelligence study by the research analysts at Market Business Insights (MBI) takes a deep dive into inner operations of the global Trastuzumab Biosimilar Market. It thoroughly examines the market landscape to give the readers an accurate insight into the current, as well as the
Trastuzumab Biosimilar Market 2022 | Detailed Report
According to Market Study Report, Trastuzumab Biosimilar Market provides a comprehensive analysis of the Trastuzumab Biosimilar Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5511273 The report provides a comprehensive analysis of company profiles listed below: - Amgen Inc. - Pfizer Inc - Samsung Bioepis -